CSL LimitedCSL LimitedCSL Limited

CSL Limited

No trades
No trades

Compare with CSL Limited


Market capitalization
‪84.05 B‬AUD
−7.59AUD
‪−3.81 B‬AUD
‪23.17 B‬AUD
‪478.59 M‬
Beta (1Y)
0.97
Next report date
Report period
EPS estimate
Revenue estimate
Employees (FY)
‪29 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪798.84 K‬AUD
Net income / Employee (1Y)
‪−131.24 K‬AUD

Company info


CEO
Gordon Naylor
Website
Headquarters
Melbourne
Founded
1961
IPO date
Jun 8, 1994
ISIN
AU000000CSL8
FIGI
BBG000BKBNS9
Identifiers
ISIN AU000000CSL8
CFI code
ESVUFR
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateApr 27, 2062
Coupon4.95% (Fixed)
Maturity dateApr 27, 2042
Coupon4.63% (Fixed)
Maturity dateApr 27, 2032
Coupon4.25% (Fixed)
Maturity dateApr 27, 2029
Coupon4.05% (Fixed)

See all CSL bonds 

Weight2.12%
Market value‪807.58 M‬
Weight0.09%
Market value‪619.19 M‬
Weight0.23%
Market value‪454.59 M‬
Weight0.13%
Market value‪412.29 M‬
Weight0.27%
Market value‪216.42 M‬
Weight3.08%
Market value‪211.45 M‬
Weight2.56%
Market value‪178.13 M‬
Weight0.53%
Market value‪170.15 M‬
Weight2.20%
Market value‪162.42 M‬
Weight3.00%
Market value‪148.28 M‬

Explore more ETFs 

Frequently asked questions


The current price of CSL is 174.50 AUD — it has decreased by −0.57% in the past 24 hours. Watch CSL Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange CSL Limited stocks are traded under the ticker CSL.
CSL stock has risen by 1.34% compared to the previous week, the month change is a 35.45% rise, over the last year CSL Limited has showed a −15.79% decrease.
We've gathered analysts' opinions on CSL Limited future price: according to them, CSL price has a max estimate of 206.86 AUD and a min estimate of 131.56 AUD. Watch CSL chart and read a more detailed CSL Limited stock forecast: see what analysts think of CSL Limited and suggest that you do with its stocks.
CSL reached its all-time high on Feb 20, 2020 with the price of 342.75 AUD, and its all-time low was 0.75 AUD and was reached on Nov 23, 1994. View more price dynamics on CSL chart.
See other stocks reaching their highest and lowest prices.
CSL stock is 1.99% volatile and has beta coefficient of 0.97. Track CSL Limited stock price on the chart and check out the list of the most volatile stocks — is CSL Limited there?
Today CSL Limited has the market capitalization of ‪84.05 B‬, it has decreased by −0.08% over the last week.
Yes, you can track CSL Limited financials in yearly and quarterly reports right on TradingView.
CSL Limited is going to release the next earnings report on Feb 9, 2027. Keep track of upcoming events with our Earnings Calendar.
CSL earnings for the last half-year are 3.27 AUD per share, whereas the estimation was 3.40 AUD, resulting in a −4.02% surprise. The estimated earnings for the next half-year are 5.54 AUD per share. See more details about CSL Limited earnings.
CSL Limited revenue for the last half-year amounts to ‪10.79 B‬ AUD, despite the estimated figure of ‪10.27 B‬ AUD. In the next half-year revenue is expected to reach ‪11.69 B‬ AUD.
CSL net income for the last half-year is ‪−4.24 B‬ AUD, while the previous report showed ‪611.97 M‬ AUD of net income which accounts for 0.00% change. Track more CSL Limited financial stats to get the full picture.
Yes, CSL dividends are paid semi-annually. The last dividend per share was 1.81 AUD. As of today, Dividend Yield (TTM)% is 2.43%. Tracking CSL Limited dividends might help you take more informed decisions.
As of Sep 5, 2026, the company has ‪29 K‬ employees. See our rating of the largest employees — is CSL Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CSL Limited EBITDA is ‪7.49 B‬ AUD, and current EBITDA margin is 32.18%. See more stats in CSL Limited financial statements.
Like other stocks, CSL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CSL Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CSL Limited technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CSL Limited stock shows the sell signal. See more of CSL Limited technicals for a more comprehensive analysis.